ZEB1 and breast cancer: Intriguingly, during breast cancer development, the accumulation of CIN is apparently prevented, if oncogene activation had taken place in mammary stem cells, engaging a ZEB1‐driven preemptive program with upregulation of the anti‐oxidant MSRB3.